TECH

BIO-TECHNE CORP

Healthcare | Mid Cap

$0.36

EPS Forecast

$290.5

Revenue Forecast

Announcing earnings for the quarter ending 2025-12-31T00:00:00 soon
DNLIDenali Therapeutics IncNVAXNovavax IncNBIXNeurocrine Biosciences IncRGENRepligen CorpCRSPCrispr Therapeutics AgMRNAModerna IncHALOHalozyme Therapeutics IncIOVAIovance Biotherapeutics IncREPLReplimune Group Inc